Generex Provides Access Information for Investor Conference Call Scheduled for January 4, 2018

Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time:

The purpose of the conference call is to provide Company stockholders and other interested parties with an update in respect of the Company’s initiatives and strategic plans.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180103005182/en/